A pharmacological study of chloramphenicol in horses.

The research investigates the effectiveness of giving a medication, chloramphenicol, to horses. The findings show that the drug does not remain in the horse’s system long enough to properly fight infections.

Research Overview

The study focuses on the pharmacological disposition of chloramphenicol, an antibiotic, in horses. The research looked at different doses of the drug given intravenously (IV), intramuscularly (IM), and orally. The purpose was to determine the effective levels of the antibiotic for combating infections in horses, how long those levels were maintained, and how the drug interacted with body components like plasma and red blood corpuscles.

Dose and Effectiveness Observations

• The desired minimum levels of the antibiotic in blood could not be achieved with certain doses.
• However, increasing the dosage proved somewhat effective for achieving the required levels, albeit for a short duration of about two to three hours.
• A combination of dosing methods, including simultaneous intravenous and intramuscular administration, did not yield longer-lasting levels than intravenous administration alone.

Chloramphenicol Variations

• The researchers found that chloramphenicol succinate, a form of the antibiotic, produced higher levels in the blood and plasma but the duration was not extended compared to the pure form of the drug.
• Additionally, this succinate salt was discovered to have minimal if any bond to red blood cells, influencing the interaction within the body and the drug’s effectiveness.

Pharmacological Properties

• Determining important properties, the plasma half-life of chloramphenicol in horses was found to be 0.98 hours, with an apparent volume of distribution of 0.92 L/kg.
• In concentrations of 5-10 mu g/ml in equine plasma, about 30 percent of the chloramphenicol binds to plasma proteins.

Conclusion

Data from the study suggests that the biological half-life of chloramphenicol is too short for it to be effectively used against systemic infections in horses. Consequently, while the drug can be administered and absorbed by the animal, it does not stay in the system long enough to provide a therapeutic benefit for combating infections.